HomeAuthorsPosts by admin

admin

1868 POSTS6 COMMENTS

Latest Pharma-News

Bayer to present new data from the company’s growing radiology portfolio

admin - July 12, 2022 0

Latest Pharma-News

COVID-19 Spreads Faster During Cold Seasons, AMREF Africa Boss Warns Kenyans

admin - July 5, 2022 0

Latest Pharma-News

Avacta announces second dose escalation in Phase I study of AVA6000 Pro-doxorubicin

admin - July 5, 2022 0

Latest Pharma-News

Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries

admin - July 5, 2022 0

Latest Pharma-News

Pfizer Announces Commitment to Accelerate Climate Action and Achieve Net-Zero Standard by 2040

admin - July 1, 2022 0

Latest Pharma-News

FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses

admin - July 1, 2022 0

Latest Pharma-News

Patient enrollment of phase III tolebrutinib trials paused in the U.S.

admin - July 1, 2022 0

Latest Pharma-News

AZ’s New study indicates that CKD is present in one out of ten adults

admin - July 1, 2022 0

Latest Pharma-News

FDA Introduces Innovative Proposal to Advance Consumer Access to Nonprescription Drugs

admin - June 30, 2022 0

Latest Pharma-News

Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine

admin - June 30, 2022 0

Latest Pharma-News

GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community

admin - June 30, 2022 0

Latest Pharma-News

Patient enrollment of phase III tolebrutinib trials paused in the U.S.

admin - June 30, 2022 0

1...141516...156 Page 15 of 156

TOP AUTHORS

admin

1868 POSTS6 COMMENTS

OIdMIHuOdiu

0 POSTS0 COMMENTS

tintin

0 POSTS0 COMMENTS

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

February 10, 2025

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

February 3, 2025

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

February 3, 2025

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

January 24, 2025

admin

TOP AUTHORS

Most Read

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Interview Questions on Institutional Review Board(IRB)

POPULAR POSTS

How to Find Paid Clinical Trials Near You

What Is CDISC and What Are CDISC Data Standards?

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

POPULAR CATEGORY

ABOUT US

FOLLOW US